These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21081945)

  • 1. The clinical utility of precision medicine: properly assessing the value of emerging diagnostic tests.
    Shen B; Hwang J
    Clin Pharmacol Ther; 2010 Dec; 88(6):754-6. PubMed ID: 21081945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Payers and the assessment of clinical utility for companion diagnostics.
    Quinn B
    Clin Pharmacol Ther; 2010 Dec; 88(6):751-4. PubMed ID: 21081944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evaluation of diagnostic tests: evidence on technical and diagnostic accuracy, impact on patient outcome and cost-effectiveness is needed.
    Van den Bruel A; Cleemput I; Aertgeerts B; Ramaekers D; Buntinx F
    J Clin Epidemiol; 2007 Nov; 60(11):1116-22. PubMed ID: 17938052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 5. Diagnostic accuracy studies.
    Manchikanti L; Derby R; Wolfer L; Singh V; Datta S; Hirsch JA
    Pain Physician; 2009; 12(3):517-40. PubMed ID: 19461821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Getting personal.
    Nature; 2011 May; 473(7347):253-4. PubMed ID: 21593815
    [No Abstract]   [Full Text] [Related]  

  • 6. The hidden cost of variability.
    Tsai M; Polk JD
    Anesth Analg; 2011 Aug; 113(2):431; author reply 431-2. PubMed ID: 21788332
    [No Abstract]   [Full Text] [Related]  

  • 7. Commentary: Personalized health planning and the Patient Protection and Affordable Care Act: an opportunity for academic medicine to lead health care reform.
    Dinan MA; Simmons LA; Snyderman R
    Acad Med; 2010 Nov; 85(11):1665-8. PubMed ID: 20844424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-generation pathology.
    Ross JS
    Am J Clin Pathol; 2011 May; 135(5):663-5. PubMed ID: 21502418
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictive value and efficiency of hematology data.
    Galen RS
    Blood Cells; 1980; 6(2):185-97. PubMed ID: 6769520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TB diagnostic tests: how do we figure out their costs?
    Sohn H; Minion J; Albert H; Dheda K; Pai M
    Expert Rev Anti Infect Ther; 2009 Aug; 7(6):723-33. PubMed ID: 19681700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical drug tests adapted for speed.
    Ledford H
    Nature; 2010 Apr; 464(7293):1258. PubMed ID: 20428134
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis.
    Dowdy DW; O'Brien MA; Bishai D
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1021-9. PubMed ID: 18713499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The profit in routine laboratory tests in an internal medicine department].
    Prins JM; Ubbink DT; Netelenbos JC
    Ned Tijdschr Geneeskd; 1985 Dec; 129(50):2403-6. PubMed ID: 3937063
    [No Abstract]   [Full Text] [Related]  

  • 14. Decision analysis model for paratuberculosis control in commercial dairy herds.
    Dorshorst NC; Collins MT; Lombard JE
    Prev Vet Med; 2006 Jul; 75(1-2):92-122. PubMed ID: 16564101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putting retinal exams for diabetics in the primary care arena.
    Clin Resour Manag; 2001 Dec; 2(12):183-6, 177. PubMed ID: 11794826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservative versus aggressive follow up of mildly abnormal Pap smears: testing for process utility.
    Birch S; Melnikow J; Kuppermann M
    Health Econ; 2003 Oct; 12(10):879-84. PubMed ID: 14508872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of dyspepsia and functional gastrointestinal disorders: a cost-benefit analysis of different approaches.
    Sonnenberg A; Townsend WF; Müller AD
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):655-9. PubMed ID: 8590161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the routine, occupation-based gonorrhea and syphilis screening program in Moscow, Russia: an analysis of sexually transmitted infection prevalence and cost-effectiveness.
    Kourbatova EV; Akovbyan VA; Chesson HW; Lytkina IN; Dmitriev GA; Tikhonova LI; Koubanova AA; Petukhova II; Latypova MF; Aboymova OA; Lewis JS; Ryan CA; Shakarishvili A
    Sex Transm Dis; 2008 May; 35(5):453-60. PubMed ID: 18434940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of diagnostic tests for toenail onychomycosis: a repeated-measure, single-blinded, cross-sectional evaluation of 7 diagnostic tests.
    Lilly KK; Koshnick RL; Grill JP; Khalil ZM; Nelson DB; Warshaw EM
    J Am Acad Dermatol; 2006 Oct; 55(4):620-6. PubMed ID: 17010741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of routine urine culture in the assessment of preterm labor.
    Hundley AF; Onderdonk AB; Greenberg JA
    J Reprod Med; 2003 Nov; 48(11):853-7. PubMed ID: 14686017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.